In addition, a subset of breast cancers with HER2 amplification exhibit an inflammatory phenotype but can also display impairment of the innate immune response through attenuation of STING activity and loss of phosphorylation of Tank-binding kinase 1.47 The gene discussed is TBK1; the disease is breast cancer.